___

• Bayley, N., & Pinneau, S.R. (1952). Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standart. J Pediatr, 40, 423-441.
• Bundak, R., Hindmarsh, P.C., & Brook, C.G.D. (1988). Long-term auxologic effects of human growth hormone. J Pediatr, 112, 875-879.
• Bundak, R., & Neyzi, O. (2010). Büyüme. In Neyzi, O., & Ertuğrul, T. (Eds.), Pediyatri (pp.89-111). İstanbul:Nobel.
• Chatelain, P. (1999). Trends in the diagnosis and treatment of short stature as revealed by KIGS. In Ranke, M.B., & Wilton, P. (Eds.), Growth hormone therapy in KIGS-10 years’ experience (pp.11-20).
• Heidelberg, Leipzig: Barth. J&J. Cole, T.J., Hindmarsh, P.C., & Dunger, D.B. (2004). Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiency. Centre for Paediatric Epidemiology and Biostatistics Arch Dis Child., 89, 1024-1027.
• Coste, J., Letrait, M., Carel, J.C. et al. (1997). Long term results of growth hormone treatment in France in children of short stature: Population, register based study. BMJ, 315, 708-713.
• Cutfield, W.S., Lindberg, A., Chatelain, P., Price, D.A., Wikland, K.A., Wilton, P., et al. (1999). Final height following growth hormone treatment of idiopatic growth hormone deficiency in KIGS. In Ranke, M.B., & Wilton, P. (Eds.), Growth hormone therapy in KIGS-10 years’ experience (pp.15-20).
• Heidelberg, Leipzig: Barth. J&J Darendeliler, F. (2009). Büyüme hormonunun tedavisinde kanıta dayalı uygulamalar. Çocuk Dergisi, 9(4), 158-166.
• Donaldson, M.D. (1997). Growth hormone therapy in Turner syndrome current uncertainties and future strategies. Horm. Res., 48, 35-44.
• Dündar, B.N. (2002). Dokuz Eylül Üniversitesi Tıp Fakültesi Pediatrik Endokrinoloji ve Metabolizma Bilim Dalı’nda 1990-2002 arasında büyüme hormonu tedavisi alan olguların tedavi sonuçları ve tedaviyi etkileyen faktörler. Tıpta uzmanlık tezi, Dokuz Eylül Üniversitesi, İzmir.
• Finkelstein, B.S., Imperiale, T.F., Speroff, T., Marrero, U., Radcliffe, D.J., & Cuttler, L. (2002). Effect of growth hormone therapy on height in children with idiopathic short stature: A meta-analysis. Arch Pediatr Adolesc Med., 156(3), 230-40.
• Huang, Y.H., Wai, Y.Y., Van, Y.H., & Lo, F.S. (2012). Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency. J Formos Med Assoc., 111(7), 355-363. doi: 10.1016/j. jfma.2011.06.011.
• Kaplan, S.L., Underwood, L.E., August, G.P., Bell, J.J., Blethen, S.L., Blizzard, R.M., et al. (1986) Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet, 1, 697-700.
• Koch, T.K., Berg, B.O., De Armond, S.J., & Gravina, R.F. (1985). Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. The New England Journal of Medicine, 313, 731-733.
• Lifshitz, F., & Botero, D. (2004). Growth and growth disorders. In Lifshitz, F. (Ed.), Pediatric Endocrinolog (pp. 1-18). Newyork: Marcel-Dekker.
• Migliaretti, G., Berchialla, P., Borraccino, A., Gregori, D., Cavallo, F. (2012). A mathematical model in the analysis of the response to growth hormone treatment in pediatric patients with diagnosis of growth hormone deficiency. Commissione GH Piemonte. J Endocrinol Invest., 35(2), 209-214.
• Narlı, N., Yıldızdaş, Y.H., & Bayazıt, K.A. (2007). Pediatrik tanı ve tedavide pratik yaklaşımlar. Adana: Nobel.
• Ohlsson, C., Isgaadr, J., Tomell, J., Nilsson, A., Isalsson, O.G.P., & Lindahl, A. (1993). Endocrine regulation of longitudinal bone growth. Acta Pediatr, 391, 33-40.
• Parkin, J.M. (1989). The short child. In Brook, C.G.D., (Ed.), Clinical pediatric endocrinology (pp. 96-117). Oxford: Blackwell Scientific Publications.
• Ranke, M.B., Price, D.A., Albertsson Wikland, K., et al. (1997). Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study. Horm Res, 48, 62-71.
• Ranke, M.B. (1996). Towards a consensus on the definition of idiopathic short stature. Hormone Research in Pediatrics, 45, 64-66
• Reiter, E.O., & Rosenfeld, R.G. (1998). Normal and aberrant growth In Wilson, I.D., Foster, D.W., Kronenberg, H.M., & Larsen, P.R. (Eds.), Williams Text book of endocrinology (pp. 1427-1507) . Philadelphia: WB Saninders Company.
• Salı, E. (2012). Büyüme hormonu eksikliği saptanan çocuk hastalarda, büyüme hormonu tedavisinin retrospektif olarak değerlendirilmesi. Tıpta uzmanlık tezi, Uludağ Üniversitesi, Bursa.
• Souza, F.M., Collett-Solberg, P.F. (2011). Adverse effects of growth hormone replacement therapy in children. Arq Bras Endocrinol Metabol, 55(8), 559-565.
• Tarım, Ö., & Sağlam, H. (2010). Büyüme Hormonu Eksikliği: Güncel Pediatri, 8, 36-38.
• Zadik, Z., Chalew, S., Zung, A., Landau, H., Lieberman, E., Koren, R., et al. (1994). Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency. J Pediatr. 125, 189-195.